Bioxcel Therapeutics, Inc. · NASDAQ:BTAI

Armistice Capital, LLC's stake in Bioxcel Therapeutics, Inc. fell to 4.99% (Schedule 13G/A)

Event Jun 30, 2026 · Filed Aug 14, 2026

Armistice Capital, LLC's stake in Bioxcel Therapeutics, Inc. fell to 4.99%, 1,621,716 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).

Stake
4.99%
Shares
1,621,716
Intent
Passive
What changed
Fell below 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Armistice Capital, LLC4.99%1,621,716
Steven Boyd4.99%1,621,716

Source

View original at SEC

Related